When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
WIZP - Wize Pharma down 9% on underwhelming LO2A data in eye disorder
Wize Pharma Inc
Thinly traded nano cap Wize Pharma (OTCQB:WIZP-8.5%) is down on more than a 4x surge in volume, albeit on turnover of only 128K shares, in reaction to its announcement of final results from a Phase 2 clinical trial evaluating lead drug LO2A, an eye drop, in patients with conjunctivochalasis, a disorder caused by redundant folds of loose conjunctiva (the mucous membrane covering the front of the eye and the inside of the eyelids) that is commonly misdiagnosed as dry eye disease.
More news on: Wize Pharma, Inc., Healthcare stocks news, Stocks on the move,